In this section
The objective of the Imperial Network for Vaccine Research is to tackle the most difficult questions facing the development and delivery of effective vaccines.
Learn more
The Antimicrobial Research Collaborative (ARC@Imperial) consolidates world-leading, multidisciplinary research across Imperial College London to synergistically address the urgent global threat of antimicrobial resistance from a 'one health' perspective.
The Imperial Network of Excellence in Vascular Science launched in 2017 to link researchers, as well as foster pipelines of research from basic to clinical and translational, to further our understanding and developments within vascular science.
The Cancer Research UK Convergence Science Centre was established as a strategic partnership between Imperial College London and The Institute of Cancer Research, London.
Imperial College London is a founding university partner of the Francis Crick Institute, which is dedicated to understanding the fundamental biology underlying health and disease.
The Wellcome Sanger Institute uses information from genome sequences to advance understanding of biology and improve health.
The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years.